3b9m › Citations

A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.

Zhu L, Yang F, Chen L, Meehan EJ, Huang M
J Struct Biol 162 40-9 (2008)
Related entries: 1uor, 2bx8, 2bxa, 2bxb, 2bxc, 2bxd, 2bxe, 2bxf, 2bxg, 2bxh, 2bxi, 2bxk, 2bxl, 2bxm, 2bxn, 2bxo, 2bxp, 2bxq, 2i2z, 2i30, 3b9l

Cited: 55 times
EuropePMC logo PMID: 18258455

Abstract

3'-Azido-3'-deoxythymidine (AZT) is the first clinically effective drug for the treatment of human immunodeficiency virus infection. The drug interaction with human serum albumin (HSA) has been an important component in understanding its mechanism of action, especially in drug distribution and in drug-drug interaction on HSA in the case of multi-drug therapy. We present here crystal structures of a ternary HSA-Myr-AZT complex and a quaternary HSA-Myr-AZT-SAL complex (Myr, myristate; SAL, salicylic acid). From this study, a new drug binding subsite on HSA Sudlow site 1 was identified. The presence of fatty acid is needed for the creation of this subsite due to fatty acid induced conformational changes of HSA. Thus, the Sudlow site 1 of HSA can be divided into three non-overlapped subsites: a SAL subsite, an indomethacin subsite and an AZT subsite. Binding of a drug to HSA often influences simultaneous binding of other drugs. From the HSA-Myr-AZT-SAL complex structure, we observed the coexistence of two drugs (AZT and SAL) in Sudlow site 1 and the competition between these two drugs in subdomain IB. These results provide new structural information on HSA-drug interaction and drug-drug interaction on HSA.

Articles - 3b9m mentioned but not cited (6)

  1. X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism. Bijelic A, Theiner S, Keppler BK, Rompel A. J Med Chem 59 5894-5903 (2016)
  2. Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma. Czub MP, Handing KB, Venkataramany BS, Cooper DR, Shabalin IG, Minor W. J Med Chem 63 6847-6862 (2020)
  3. Human Serum Albumin Facilitates Heme-Iron Utilization by Fungi. Pinsky M, Roy U, Moshe S, Weissman Z, Kornitzer D. mBio 11 e00607-20 (2020)
  4. Proteomic and molecular dynamic investigations of PTM-induced structural fluctuations in breast and ovarian cancer. Tikhonov D, Kulikova L, Kopylov AT, Rudnev V, Stepanov A, Malsagova K, Izotov A, Kulikov D, Zulkarnaev A, Enikeev D, Potoldykova N, Kaysheva AL. Sci Rep 11 19318 (2021)
  5. Destabilization of amyloid fibrils on interaction with MoS2-based nanomaterials. Mudedla SK, Murugan NA, Subramanian V, Agren H. RSC Adv 9 1613-1624 (2019)
  6. PETRA: Drug Engineering via Rigidity Analysis. Herr S, Myers-Dean J, Read H, Jagodzinski F. Molecules 25 E1304 (2020)


Reviews citing this publication (10)

  1. Albumin-drug interaction and its clinical implication. Yamasaki K, Chuang VT, Chuang VT, Maruyama T, Otagiri M. Biochim Biophys Acta 1830 5435-5443 (2013)
  2. Interactive association of drugs binding to human serum albumin. Yang F, Zhang Y, Liang H. Int J Mol Sci 15 3580-3595 (2014)
  3. Fatty acid binding to serum albumin: molecular simulation approaches. Fujiwara S, Amisaki T. Biochim Biophys Acta 1830 5427-5434 (2013)
  4. Serum Albumin: A Multifaced Enzyme. De Simone G, di Masi A, Ascenzi P. Int J Mol Sci 22 10086 (2021)
  5. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients. Ferrer R, Mateu X, Maseda E, Yébenes JC, Aldecoa C, De Haro C, Ruiz-Rodriguez JC, Garnacho-Montero J. Expert Rev Clin Pharmacol 11 125-137 (2018)
  6. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds. Stoll F, Göller AH, Hillisch A. Drug Discov Today 16 530-538 (2011)
  7. In silico prediction of human serum albumin binding for drug leads. Vallianatou T, Lambrinidis G, Tsantili-Kakoulidou A. Expert Opin Drug Discov 8 583-595 (2013)
  8. Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems. Rudakovskaya PG, Barmin RA, Kuzmin PS, Fedotkina EP, Sencha AN, Gorin DA. Pharmaceutics 14 1236 (2022)
  9. Exploration of ligand-induced protein conformational alteration, aggregate formation, and its inhibition: A biophysical insight. Nusrat S, Khan RH. Prep Biochem Biotechnol 48 43-56 (2018)
  10. Unraveling the versatility of human serum albumin - A comprehensive review of its biological significance and therapeutic potential. Ashraf S, Qaiser H, Tariq S, Khalid A, Makeen HA, Alhazmi HA, Ul-Haq Z. Curr Res Struct Biol 6 100114 (2023)

Articles citing this publication (39)

  1. Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. Ryan AJ, Ghuman J, Zunszain PA, Chung CW, Curry S. J Struct Biol 174 84-91 (2011)
  2. Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin. Hein KL, Kragh-Hansen U, Morth JP, Jeppesen MD, Otzen D, Møller JV, Nissen P. J Struct Biol 171 353-360 (2010)
  3. Structural mechanism of ring-opening reaction of glucose by human serum albumin. Wang Y, Yu H, Shi X, Luo Z, Lin D, Huang M. J Biol Chem 288 15980-15987 (2013)
  4. Challenges and advances in validating enzyme design proposals: the case of kemp eliminase catalysis. Frushicheva MP, Cao J, Warshel A. Biochemistry 50 3849-3858 (2011)
  5. Investigations with spectroscopy, zeta potential and molecular modeling of the non-cooperative behaviour between cyclophosphamide hydrochloride and aspirin upon interaction with human serum albumin: binary and ternary systems from multi-drug therapy. Omidvar Z, Parivar K, Sanee H, Amiri-Tehranizadeh Z, Baratian A, Saberi MR, Asoodeh A, Chamani J. J Biomol Struct Dyn 29 181-206 (2011)
  6. Crystallographic studies of the complexes of bovine and equine serum albumin with 3,5-diiodosalicylic acid. Sekula B, Zielinski K, Bujacz A. Int J Biol Macromol 60 316-324 (2013)
  7. A novel tumor targeting drug carrier for optical imaging and therapy. Li R, Zheng K, Hu P, Chen Z, Zhou S, Chen J, Yuan C, Chen S, Zheng W, Ma E, Zhang F, Xue J, Chen X, Huang M. Theranostics 4 642-659 (2014)
  8. QSAR models for the prediction of plasma protein binding. Ghafourian T, Amin Z. Bioimpacts 3 21-27 (2013)
  9. Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. Ascenzi P, di Masi A, De Sanctis G, Coletta M, Fasano M. Biochem Biophys Res Commun 387 83-86 (2009)
  10. Structural basis of transport of lysophospholipids by human serum albumin. Guo S, Shi X, Yang F, Chen L, Meehan EJ, Bian C, Huang M. Biochem J 423 23-30 (2009)
  11. Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin. Zhang Y, Lee P, Liang S, Zhou Z, Wu X, Yang F, Liang H. Chem Biol Drug Des 86 1178-1184 (2015)
  12. Crystallographic analysis reveals the structural basis of the high-affinity binding of iophenoxic acid to human serum albumin. Ryan AJ, Chung CW, Curry S. BMC Struct Biol 11 18 (2011)
  13. Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release. Li S, Yuan C, Chen J, Chen D, Chen Z, Chen W, Yan S, Hu P, Xue J, Li R, Zheng K, Huang M. Theranostics 9 884-899 (2019)
  14. Nonprotein based enrichment method to analyze peptide cross-linking in protein complexes. Yan F, Che FY, Rykunov D, Nieves E, Fiser A, Weiss LM, Hogue Angeletti R. Anal Chem 81 7149-7159 (2009)
  15. Spectroscopic and molecular modeling study on the separate and simultaneous bindings of alprazolam and fluoxetine hydrochloride to human serum albumin (HSA): with the aim of the drug interactions probing. Dangkoob F, Housaindokht MR, Asoodeh A, Rajabi O, Rouhbakhsh Zaeri Z, Verdian Doghaei A. Spectrochim Acta A Mol Biomol Spectrosc 137 1106-1119 (2015)
  16. Assessment of the interaction procedure between Pt(IV) prodrug [Pt(5,5'-dmbpy)Cl4 and human serum albumin: Combination of spectroscopic and molecular modeling technique. Shahraki S, Saeidifar M, Shiri F, Heidari A. J Biomol Struct Dyn 35 3098-3106 (2017)
  17. A fluorescent fatty acid probe, DAUDA, selectively displaces two myristates bound in human serum albumin. Wang Y, Luo Z, Shi X, Wang H, Nie L, Huang M. Protein Sci 20 2095-2101 (2011)
  18. Immobilised histidine tagged β2-adrenoceptor oriented by a diazonium salt reaction and its application in exploring drug-protein interaction using ephedrine and pseudoephedrine as probes. Li Q, Bian L, Zhao X, Gao X, Zheng J, Li Z, Zhang Y, Jiang R, Zheng X. PLoS One 9 e94955 (2014)
  19. Combination of chiroptical, absorption and fluorescence spectroscopic methods reveals multiple, hydrophobicity-driven human serum albumin binding of the antimalarial atovaquone and related hydroxynaphthoquinone compounds. Zsila F, Fitos I. Org Biomol Chem 8 4905-4914 (2010)
  20. Human serum albumin: A modulator of cannabinoid drugs. Leboffe L, di Masi A, Trezza V, Polticelli F, Ascenzi P. IUBMB Life 69 834-840 (2017)
  21. Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation. Ascenzi P, Cao Y, Tundo GR, Coletta M, Fanali G, Fasano M. Biochem Biophys Res Commun 411 185-189 (2011)
  22. Confirming therapeutic target of protopine using immobilized β2 -adrenoceptor coupled with site-directed molecular docking and the target-drug interaction by frontal analysis and injection amount-dependent method. Liu G, Wang P, Li C, Wang J, Sun Z, Zhao X, Zheng X. J Mol Recognit 30 (2017)
  23. Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design. Dargó G, Bajusz D, Simon K, Müller J, Balogh GT, Balogh GT. J Med Chem 63 1763-1774 (2020)
  24. Stepwise frontal affinity chromatography model for drug and protein interaction. He X, Sui Y, Wang S. Anal Bioanal Chem 410 5807-5815 (2018)
  25. X-ray crystallographic and fluorometric analysis of the interactions of rhein to human serum albumin. Li M, Lee P, Zhang Y, Ma Z, Yang F, Zhou Z, Wu X, Liang H. Chem Biol Drug Des 83 167-173 (2014)
  26. Research Support, Non-U.S. Gov't HSA-based anti-inflammatory therapy: a new and improved approach. Liang H, Yang F, Lee N, Wu X. Future Med Chem 6 119-121 (2014)
  27. Calorimetric investigation of diclofenac drug binding to a panel of moderately glycated serum albumins. Indurthi VS, Leclerc E, Vetter SW. Eur J Pharm Sci 59 58-68 (2014)
  28. Effect of Caffeine and Flavonoids on the Binding of Tigecycline to Human Serum Albumin: A Spectroscopic Study and Molecular Docking. Sovrlić M, Mrkalić E, Jelić R, Ćendić Serafinović M, Stojanović S, Prodanović N, Tomović J. Pharmaceuticals (Basel) 15 266 (2022)
  29. Role of the conformational flexibility of evodiamine in its binding to protein hosts: a comparative spectroscopic and molecular modeling evaluation with rutaecarpine. Domonkos C, Fitos I, Visy J, Zsila F. Phys Chem Chem Phys 16 22632-22642 (2014)
  30. A Comprehensive Spectroscopic Analysis of the Ibuprofen Binding with Human Serum Albumin, Part I. Ploch-Jankowska A, Pentak D. Pharmaceuticals (Basel) 13 E205 (2020)
  31. Association of valdecoxib, a nonsteroidal anti-inflammatory drug, with human serum albumin. Encinas MV, Lissi E, Vergara C. Photochem Photobiol 89 1399-1405 (2013)
  32. Comparison of binding characterization of two antiviral drugs to human serum albumin. Li M, McAuley E, Zhang Y, Kong L, Yang F, Zhou Z, Wu X, Liang H. Chem Biol Drug Des 83 576-582 (2014)
  33. Spectroscopic and computational approaches to unravel the mode of binding between a isoflavone, biochanin-A and calf thymus DNA. Pawar S, Tandel R, Kunabevu R, Jaldappagari S. J Biomol Struct Dyn 37 846-856 (2019)
  34. Spectroscopy, Structure, Biomacromolecular Interactions, and Antiproliferation Activity of a Fe(II) Complex With DPA-Bpy as Pentadentate Ligand. Bai H, Shi J, Guo Q, Wang W, Zhang Z, Li Y, Vennampalli M, Zhao X, Wang H. Front Chem 10 888693 (2022)
  35. An Informatics-based Approach to Identify Key Pharmacological Components in Drug-Drug Interactions. Deng J, Wang F. AMIA Jt Summits Transl Sci Proc 2020 142-151 (2020)
  36. Computational simulations determining disulfonic stilbene derivative bioavailability within human serum albumin. Jaunet-Lahary T, Vercauteren DP, Fleury F, Laurent AD. Phys Chem Chem Phys 20 18020-18030 (2018)
  37. Crystal structures of human serum albumin in complex with lysophosphatidylcholine. Wang Y, Luo Z, Morelli X, Xu P, Jiang L, Shi X, Huang M. Biophys J 122 4135-4143 (2023)
  38. Efficient mRNA Delivery with Lyophilized Human Serum Albumin-Based Nanobubbles. Kida H, Yamasaki Y, Feril LB, Endo H, Itaka K, Tachibana K. Nanomaterials (Basel) 13 1283 (2023)
  39. Modification of the structural stability of human serum albumin in rheumatoid arthritis. Lin HL, Parkinson DH, Holman JC, Thompson WC, Anderson CNK, Hadfield M, Ames S, Zuniga Pina NR, Bowden JN, Quinn C, Hansen LD, Price JC. PLoS One 18 e0271008 (2023)


Related citations provided by authors (3)

  1. Structural basis of the drug-binding specificity of human serum albumin.. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S J Mol Biol 353 38-52 (2005)
  2. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin.. Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M J Struct Biol 157 348-55 (2007)
  3. Atomic structure and chemistry of human serum albumin.. He XM, Carter DC Nature 358 209-15 (1992)

Quick links